Market Place
Sourcing Support
Sigmapharm`s Generic Apixaban Receives approval in the U.S.
01 Feb 2022 //
FDA
Enforcement Report - Week of October 6, 2021
06 Oct 2021 //
FDA
Enforcement Report - Week of September 1, 2021
01 Sep 2021 //
FDA
Sigmapharm Labs LLC Generic Apixaban Receives Approval In The US
14 Sep 2020 //
FDA
Sigmapharm Labs`s Generic Apixaban Receives Tentative Approval In US
10 Sep 2020 //
FDA
Sigmapharm Labs LLC Generic Ticagrelor Receives Approval In The US
07 Apr 2020 //
FDA
Sigmapharm Labs Llc Asenapine Maleate Receives Approval In The US
21 Jul 2018 //
FDA
Sigmapharm Lab’s Generic Nitroglycerin Receives Approval In US
09 May 2018 //
FDA
Trintellix® ( vortioxetine hydrobromide): H. Lundbeck v. Sigmapharm Lab
03 May 2018 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Sigmapharm Laboratories
10 Apr 2017 //
PATENT LITIGATION
Sigmapharm Labs Llc Generic Potassium Chloride Receives FDA Approval
19 Aug 2016 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.